SciSparc Investor
SciSparc is a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments.
Technology:
Biologics
Industry:
PharmTech
Headquarters:
Giv'atayim, Tel Aviv, Israel
Founded Date:
2014-01-01
Employees Number:
1-10
Total Funding:
18149079
Last Funding Date:
2022-05-27
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership